Stocks›Healthcare
WatchAlert

CORONA Remedies Limited

CORONA · NSE · Healthcare · As of 8 Nov 2026
₹2,534.20
+₹93.10 (+3.81%)(1D)
₹1,336.60Since listing range₹2,584.00
Market Cap
₹15,499 Cr
P/E (Sector)
74.9 (32.3)
P/B Ratio
20.75
Dividend Yield
0.39%
ROE
24.8%
Debt / Equity
0.22
Anvest Score
65/100
  • Valuation
    15
  • Quality
    100
  • Growth
    46
  • Health
    81
  • Momentum
    86

Fundamentals

P/E Ratio (TTM)
74.87
Sector median P/E
32.29
P/B Ratio
20.75
Sector median P/B
4.4
EPS (TTM)
₹33.85
Market Cap
₹15,499 Cr
Dividend Yield
0.39%
ROE
24.79%
ROCE
27.23%
Profit Margin
13.09%
Debt/Equity
0.22
Current Ratio
0.96
Interest Coverage
35.49
Book Value
₹122.11
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

CORONA Remedies Limited FAQs

3 topics
Expand
What does the CORONA Remedies Limited (CORONA) stock page cover?
CORONA Remedies Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for CORONA?
CORONA Remedies Limited is currently shown with a delayed price near ₹2,534.2, P/E 74.87, and ROE 24.79%.
Does the CORONA page provide investment advice?
No. The CORONA page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights